-
October 26, 2020
How an Expert Would Manage His Own Stage 4 Pancreatic Cancer
With:When confronted with a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Cancer Commons Expert Physician Advisor John Strickler, MD, how he would handle his own diagnosis of metastatic pancreatic cancer. Dr. Strickler is Associate Professor of Medicine in the Division of Medical Oncology at Duke University and Co-Leader of… Read more »
-
October 18, 2021
Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience Bookmark
George Lundberg, MDThis scientific manuscript from Cureus reports results from a Toronto cancer center suggesting that stereotactic radiotherapy offers another option for palliative treatment of inoperable pancreatic cancer.
.
-
August 11, 2021
Researching More Second-Line Options for Pancreatic Cancer Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: A clinical trial is testing a promising treatment called eryaspase to see how well it performs as a second-line option for metastatic pancreatic cancer.
.
SEE ALL
Tony
Pancreatic cancer patient
-
March 22, 2022
Immunotherapy to Treat Cancer Bookmark
George Lundberg, MDImmunotherapy uses biological substances, such as your own immune system, to attack cancer cells. Learn more about immunotherapy from the National Cancer Institute.
.
-
March 22, 2022
Biomarker Testing for Cancer Treatment Bookmark
George Lundberg, MDEach person with cancer has unique biomarkers that may determine how well specific treatments might work for them. Learn more from this website all about biomarkers, prepared by the National Cancer Institute.
.
SEE ALL
Some of the most promising new treatments for metastatic pancreatic cancer are currently being tested in volunteer patients enrolled in clinical trials. We help you stay up to date on the latest results from these studies.
-
December 2, 2019
Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial Bookmark
George Lundberg, MDResearch paper from Annals of Surgery curated by Editor in Chief George Lundberg, MD, who notes:
This clinical trial found no difference in tumor-free margins from standard versus artery-first surgical techniques for the resection of pancreatic head adenocarcinoma via pancreatoduodenectomy.
Go to full paper published in Annals of Surgery.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
SEE ALL

Gavin Gordon, PhD
Molecular Pathologist
Cancer affects many aspects of life, whether you’re newly diagnosed, in the midst of treatment, or in follow-up care. Learn about ways to maintain quality of life, such as palliative care and managing side effects.
-
October 14, 2019
Pediatric Palliative Care: A Specialty Comes of Age
For a child with cancer, palliative care can provide much-needed relief from stress and symptoms—for the patient and their family alike. Palliative care is given alongside cancer treatment, and is not synonymous with “end-of-life” care. In fact, anyone with a serious illness can benefit from palliative care, no matter their long-term outlook. Because of its importance for children with cancer, we are honored to… Read more »
-
February 18, 2022
Mental Health and Pancreatic Cancer Bookmark
George Lundberg, MDCoping with a potentially lethal cancer presents many serious challenges. This article from Cancer Commons partner Let’s Win! Pancreatic Cancer might help.
.
-
August 11, 2021
Anxiety Before Each Chemotherapy Treatment Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Pancreatic cancer patients share their experiences with pre-chemo anxiety and their personal strategies for overcoming it.
.
SEE ALL
Learn more about what’s new in advanced cancer research and treatment, including screening and statistics, using artificial intelligence to improve treatment, and other new horizons in cancer care.
-
April 13, 2022
Cancer Commons Adapts to Remain True to Our Mission
With:People facing advanced cancer come to Cancer Commons to ensure they have all the information they need to make their best-possible cancer care decisions. Here, Curious Dr. George asks our CFO & COO Shelley Frisbie about recent updates to our organization. Curious Dr. George: You have been the CFO of Cancer Commons for some time and recently added the COO title and duties to… Read more »
-
March 16, 2022
Cellular Aging and the Development of Cancer
With: Kaumudi Bhawe, PhDCancer is so often a disease of older people that a whole medical field, “oncogeriatrics,” exists to address the topic. Deeper understanding of the links between cancer and aging could lead to better treatments. Here, our Curious Dr. George asks Cancer Commons Clinical Scientist Kaumudi Bhawe, PhD, about the relationship between cancer and aging processes that occur in individual cells in our bodies—throughout our… Read more »
SEE ALL
The coronavirus pandemic presents unprecedented challenges to cancer patients. We can help you understand how COVID-19 might impact your treatment and other aspects of your cancer care.
-
February 20, 2021
COVID-19 Vaccination: The VOICE for Patients with Cancer Bookmark
George Lundberg, MDThis piece from the scientific journal Nature Medicine describes a new clinical trial studying vaccination against COVID-19 specifically in patients with cancer.
.
-
February 20, 2021
Patients with Cancer Less Likely to Enroll in Clinical Trials Due to COVID-19 Bookmark
George Lundberg, MDFewer patients with cancer may be willing to enter a clinical trial. This Cancer Network article explains why and offers solutions.
.
SEE ALL